PER-010-04已完成未知
CLINICAL UTILITY OF AMLODIPINE / ATORVASTATIN TO IMPROVE THE CONDITIONAL CARDIOVASCULAR RISK FACTORS OF HYPERTENSION AND DISLIPIDEMIA (GEMINI-AALA)
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- PFIZER S.A.,
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Clinical diagnosis of high blood pressure and low density lipoprotein cholesterol levels, which require medication.
排除标准
- •Patients with blood pressure maintained adequately to the target with or without medication
- •Patients currently receiving treatment with amlodipine and atorvastatin or who are not at blood pressure or lipid level while taking the highest dose of amlodipine or atorvastatin, respectively
研究者
相似试验
进行中（未招募）
1 期
EFFICACY AND SAFETY OF AMLODIPINE USED AS ADD-ON THERAPY IN MODERATELY TO SEVERELY HYPERTENSIVE PATIENTS NOT ADEQUATELY CONTROLLED BY OLMESARTAN MEDOXOMIL 20 MG MONOTHERAPY. Eficacia y seguridad de amlodipino utilizado como terapìa adicional en pacientes con hipertensión moderada a severa no controlada adecuadamente con olmesartán medoxomilo 20 mg en monoterapiaessential hypertensionMedDRA version: 7.0Level: LLTClassification code 10015488EUCTR2005-000447-28-ESSankyo Pharma GmbH429
进行中（未招募）
不适用
EFFICACY AND SAFETY OF AMLODIPINE USED AS ADD-ON THERAPY IN MODERATELY TO SEVERELY HYPERTENSIVE PATIENTS NOT ADEQUATELY CONTROLLED BY OLMESARTAN MEDOXOMIL 20 MG MONOTHERAPYEUCTR2005-000447-28-DESankyo Pharma GmbH429
已完成
不适用
The study for the efficacy of amlodipine/atorvastatin combination drug in patients with type 2 diabetes complicated with hypertention and hypercholestrolemia.Type 2 diabetes complicated with hypertention and hypercholestrolemiaJPRN-UMIN000010895Kanazawa Medical University Diabetes and Endocrinology240
尚未招募
1 期
A TRIAL TO STUDY THE EFFECTS OF ATORVASTATIN IN PATIENTS WITH CHRONIC SCHIZOPHRENIACTRI/2019/01/017304CENTRAL INSTITUTE OF PSYCHIATRY
已完成
不适用
Study of clinical utility of amlodipine OD 5mg tablet Chemiphar to the patients with essential hypertensioJPRN-UMIN000002626Shiba Palace Clinic50